176 related articles for article (PubMed ID: 24878926)
1. Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.
Malek A; Raeeskarami SR; Ziaee V; Aghighi Y; Moradinejad MH
Clin Rheumatol; 2014 Aug; 33(8):1113-8. PubMed ID: 24878926
[TBL] [Abstract][Full Text] [Related]
2. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases.
Sato JO; Sallum AM; Ferriani VP; Marini R; Sacchetti SB; Okuda EM; Carvalho JF; Pereira RM; Len CA; Terreri MT; Lotufo SA; Romanelli PR; Ramos VC; Hilario MO; Silva CA; Corrente JE; Saad-Magalhães C;
Clin Exp Rheumatol; 2009; 27(6):1031-8. PubMed ID: 20149327
[TBL] [Abstract][Full Text] [Related]
3. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
Prasad S; Misra R; Agarwal V; Lawrence A; Aggarwal A
Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
[TBL] [Abstract][Full Text] [Related]
4. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis.
Lin TW; Hu YC; Chiang BL
J Microbiol Immunol Infect; 2023 Apr; 56(2):416-423. PubMed ID: 36572597
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis].
Ito S; Miyamae T; Imagawa T; Katakura S; Mori M; Tomono J; Ibe M; Mituda T; Aihara Y; Yokota S
Ryumachi; 1998 Dec; 38(6):785-92. PubMed ID: 10047716
[TBL] [Abstract][Full Text] [Related]
7. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
Cancarini P; Nozawa T; Whitney K; Bell-Peter A; Marcuz JA; Taddio A; Guo J; Dover S; Feldman BM
Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
[TBL] [Abstract][Full Text] [Related]
8. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
Fisler RE; Liang MG; Fuhlbrigge RC; Yalcindag A; Sundel RP
J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
[TBL] [Abstract][Full Text] [Related]
9. The arthritis of inflammatory childhood myositis syndromes.
Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
[TBL] [Abstract][Full Text] [Related]
10. Medications received by patients with juvenile dermatomyositis.
Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
[TBL] [Abstract][Full Text] [Related]
11. Juvenile dermatomyositis in Thai children.
Singalavanija S; Liamsuwan S; Limpongsanurak W; Raungsuwan S
J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.
Al-Mayouf SM; AlMutiari N; Muzaffer M; Shehata R; Al-Wahadneh A; Abdwani R; Al-Abrawi S; Abu-Shukair M; El-Habahbeh Z; Alsonbul A
Rheumatol Int; 2017 Sep; 37(9):1513-1517. PubMed ID: 28685324
[TBL] [Abstract][Full Text] [Related]
13. [Juvenile dermatomyositis].
Dressler F; Huppertz HI
Z Rheumatol; 2006 Nov; 65(7):587-90, 592-4. PubMed ID: 17051362
[TBL] [Abstract][Full Text] [Related]
14. Juvenile dermatomyositis with IgA nephropathy: case-based review.
Mantoo MR; Tripathy SK; Phulware RH; Bagri NK; Hari P; Barwad A
Rheumatol Int; 2019 Mar; 39(3):577-581. PubMed ID: 30552457
[TBL] [Abstract][Full Text] [Related]
15. Dermatomyositis and polymyositis in childhood.
Chung HT; Huang JL; Wang HS; Hung PC; Chou ML
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):407-14. PubMed ID: 7942027
[TBL] [Abstract][Full Text] [Related]
16. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
[TBL] [Abstract][Full Text] [Related]
17. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].
Constantin T; Ponyi A; Kálovics T; Orbán I; Molnár K; Dérfalvy B; Dicso F; Sallai A; Garami M; Balogh Z; Szalai Z; Fekete G; Dankó K
Orv Hetil; 2007 Oct; 148(42):1989-97. PubMed ID: 17932005
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and disease course of patients with juvenile dermatomyositis.
Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
[TBL] [Abstract][Full Text] [Related]
19. Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.
Walling HW; Gerami P; Sontheimer RD
Paediatr Drugs; 2010; 12(1):23-34. PubMed ID: 20034339
[TBL] [Abstract][Full Text] [Related]
20. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
